AsisChem Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AsisChem's estimated annual revenue is currently $930k per year.(i)
  • AsisChem's estimated revenue per employee is $155,000

Employee Data

  • AsisChem has 6 Employees.(i)
  • AsisChem grew their employee count by -14% last year.

AsisChem's People

NameTitleEmail/Phone
1
CEO & Co-FounderReveal Email/Phone
2
Chief Financial Officer, USReveal Email/Phone
3
VP Medicinal Chemistry, USReveal Email/Phone
4
Consultant, Medicinal ChemistryReveal Email/Phone
5
Dir Chemistry, RussiaReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is AsisChem?

AsisChem is the only US company that leverages expert chemistry teams in St. Petersburg, Russia to support drug discovery projects worldwide. Since 2005 companies looking to advance drug discovery projects have entrusted AsisChem's scientists with their hit-to-lead and lead optimization efforts. AsisChem's medicinal chemistry team members have dozens of years of drug discovery experience and act as medicinal chemistry program leaders for AsisChem's customers. AsisChem's synthetic team of 30 PhD chemists has three core groups: medicinal chemistry support, process optimization and research. More than 100 different organizations have used AsisChem's services since its inception. 55% of AsisChem's current customers are pharmaceutical and biotechnology companies, four of which are publicly traded. AsisChem is also a preferred partner for dozens of universities and non-profit institutes.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M620%N/A
#2
$0.4M6N/AN/A
#3
$0.4M6N/AN/A
#4
$0.4M6-25%N/A
#5
$0.9M6-14%N/A